MYSZ · My Size, Inc.

The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.77 to $0.79 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.

Up to 20,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.

Common stock beneficially owned by Reporting Perosn's Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the Plan.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Up to 20,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

The restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

10,000 restricted shares vest upon grant date.

40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Up to 60,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

75,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.

Up to 125,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.

15,000 restricted shares vest on December 31, 2025, subject to the Reporting Person's spouse continued service to the Issuer as of such vesting date.

Common stock beneficially owned by Reporting Person's Spouse (Director and Chief Executive Officer Ronen Luzon) under the Plan.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

75,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Up to 125,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

15,000 restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Options acquired by Spouse (Chief Executive Officer Ronen Luzon).

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Options acquired by Spouse (Chief Executive Officer Ronen Luzon).

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan.

Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan.

Common stock beneficially owned by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the My Size, Inc. 2017 Equity Incentive Plan.

Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan.

Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $5.42 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date.

Common stock beneficially owned by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the My Size, Inc. 2017 Equity Incentive Plan.

Restricted stock units granted under the My Size, Inc. 2017 Equity Incentive Plan, which vest on January 1, 2025.

Restricted stock units granted under the My Size, Inc. 2017 Equity Incentive Plan, which vest on January 1, 2025.

Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date.

Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan.